Mixed options sentiment in ImmunityBio (IBRX), with shares down 19c near $8.20. Options volume relatively light with 16k contracts traded and calls leading puts for a put/call ratio of 0.36, compared to a typical level near 0.29. Implied volatility (IV30) dropped 5.29 near 114.66,and above the 52wk median, suggesting an expected daily move of $0.59. Put-call skew flattened, suggesting a modestly bullish tone.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IBRX:
- Morning Movers: Adobe falls with Narayen set to exit as CEO
- ImmunityBio reports 64 subjects complete apheresis collection in NK2022, NK2023
- ImmunityBio assumed with a Buy at BTIG
- Buy Rating on ImmunityBio Driven by ANKTIVA’s Rapid Commercial Ramp, Global Expansion, and Pipeline Catalysts
- ImmunityBio Earnings Call: ANKTIVA Surge Amid High Burn